Equity
Articles
-
It's No Accident That Drugs Are Expensive
Branded drugs are expensive in large part because it's expensive and risky to develop ... -
Will Immunotherapy Disrupt The Oncology Market?
Immunotherapy could radically change the treatment of cancer, and the revenue opportunities ... -
Big Pharma Faces 'Pay For Delay' Lawsuits
Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve ... -
Why Is Monsanto Evil, But DuPont Isn't?
Monsanto is perhaps the most-hated company, but competitors like DuPont behave in ... -
How To Interpret Thursday's Supreme Court Ruling ...
Thursday's Supreme Court ruling is a blow to Myriad but investors haven't yet digested ... -
Know Your Stock Cost Basis
Understanding equity cost basis is critical for tracking the gains or losses of an ...
Definitions
Stock Analysis
-
Pandora Gets A New CEO: Is It Enough?
Pandora announced September 12 that it had hired Brian McAndrews as its new CEO replacing ... -
Domtar Jumps 16% On Plant Closing: Time To Buy?
Domtar (NYSE:UFS) jumped the most in four years on news International Paper (NYSE:IP) ... -
The Time For Retail Real Estate Is Now
Driven by cost-cutting consumers and high unemployment, firms operating the shopping ... -
Urban Outfitters Plunges, Five Below Soars: Which ...
The two retailers went in opposite directions September 10 after both made earnings-related ... -
Is Jarden Burning The Candle From Both Ends? ...
On September 3 Jarden (NYSE:JAH) announced it was acquiring Yankee Candle Company ... -
OmniVision Technologies – The Beat(ing) Goes ...
Weaker handset demand and disappointing margins send the shares down sharply again.
Free Annual Reports